Recruitment

Recruitment Status
Completed

Summary

Conditions
Peripheral Arterial Disease
Type
Interventional
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Min Age
18
Max Age
125
Gender
Both

Description

This study is a prospective, multicenter, non-randomized single-arm clinical study to evaluate the safety and efficacy of the VIABAHN BX for the treatment of arterial occlusive disease in patients with de novo or restenotic lesions in the common and/or external iliac arteries.

This study is a prospective, multicenter, non-randomized single-arm clinical study to evaluate the safety and efficacy of the VIABAHN BX for the treatment of arterial occlusive disease in patients with de novo or restenotic lesions in the common and/or external iliac arteries.

Locations

West Des Moines, Iowa, 50266
Columbus, Ohio, 43214
New York, New York, 10065
Kingsport, Tennessee, 37660
Elk Grove Village, Illinois, 60007
...
West Des Moines, Iowa, 50266
Columbus, Ohio, 43214
New York, New York, 10065
Kingsport, Tennessee, 37660
Elk Grove Village, Illinois, 60007
Plymouth, Minnesota, 55422
Chattanooga, Tennessee, 37403
Morristown, New Jersey, 07960
Duluth, Minnesota, 55805
Fargo, North Dakota, 58122
Phoenix, Arizona, 85006
Camp Hill, Pennsylvania, 17011
Louisville, Kentucky, 40202
Norfolk, Virginia, 23507
Pittsburgh, Pennsylvania, 15213
Houston, Texas, 77030
Buffalo, New York, 14203
Greenville, South Carolina, 29615
Miami, Florida, 33136
Providence, Rhode Island, 02906
Teaneck, New Jersey, 07666
Auckland
New Haven, Connecticut, 06518
Pensacola, Florida, 32504
Charleston, South Carolina, 29425
Miami, Florida, 33176
Washington, District of Columbia, 20782

Tracking Information

NCT #
NCT02080871
Collaborators
Not Provided
Investigators
  • Principal Investigator: Jean Bismuth, MD The Methodist Hospital System
  • Jean Bismuth, MD The Methodist Hospital Research Institute